Search results
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 3 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
Stock Market Crash Warning: Don't Get Caught Holding These 3 Cathie Wood Stocks
InvestorPlace· 2 days agoFor a time, Cathie Wood was the hottest investor on Wall Street. Ark Invest was bringing in billions of dollars in new assets under management. A February report found that in aggregate, her ...
Arbutus Biopharma Corp Reports Q1 2024 Earnings: A Detailed Financial Review
GuruFocus.com via Yahoo Finance· 2 days agoLitigation and Intellectual...Arbutus continues to defend its intellectual property vigorously, particularly in ongoing litigation with Moderna and Pfizer/BioNTech over lipid ...
Arbutus Biopharma Corp Reports Q1 2024 Earnings: A Detailed Fina
Guru Focus· 2 days agoRevenue: Reported at $1.5 million for Q1 2024, a significant decrease from $6.7 million in Q1 2023, falling short of the estimated $2.15 million.Net Loss: Reco